Literature DB >> 1677908

Cell recovery during segmental intestinal perfusion in healthy subjects and patients with Crohn's disease.

O Ahrenstedt1, F Knutson, L Knutson, M Krog, O Sjöberg, R Hällgren.   

Abstract

The recovery of cells arising from small intestinal mucosa alone was studied during continuous perfusion of a closed segment of jejunum. The perfusion technique minimised the contamination of the perfused segment with, for example, proteolytic enzymes from pancreas, allowing recovery of viable cells. The use of hyaluronidase in the perfusion fluid increased the recovery of cells fivefold, the median recovery being 8 x 10(6) cells. The cells were analysed with monoclonal antibodies and flow cytometry. Nearly all cells (98-99%) recovered during perfusion of healthy control subjects and patients with Crohn's disease were epithelial cells. The jejunal cells expressed HLA-DR in similar proportions--around 30%--in patients and control subjects. The ratio between CD4+ and CD8+ lymphocytes was similar (0.2) in control subjects and patients with inactive Crohn's disease but decreased (0.03) in patients with active Crohn's disease in the ileum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677908      PMCID: PMC1378802          DOI: 10.1136/gut.32.2.170

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Hyaluronic acid and type III procollagen peptide in jejunal perfusion fluid as markers of connective tissue turnover.

Authors:  J F Colombel; R Hällgren; A Engström-Laurent; J C Rambaud
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

2.  A new technique for segmental jejunal perfusion in man.

Authors:  L Knutson; B Odlind; R Hällgren
Journal:  Am J Gastroenterol       Date:  1989-10       Impact factor: 10.864

3.  Ubiquitous expression of HLA-DR antigens on human small intestinal epithelium.

Authors:  M Chiba; M Iizuka; O Masamune
Journal:  Gastroenterol Jpn       Date:  1988-04

Review 4.  Why study T cell subsets in Crohn's disease?

Authors:  A Ferguson
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

5.  The jejunal secretion of histamine is increased in active Crohn's disease.

Authors:  L Knutson; O Ahrenstedt; B Odlind; R Hällgren
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

6.  Cell loss from small intestinal mucosa: a morphological study.

Authors:  I J Pink; D N Croft; B Creamer
Journal:  Gut       Date:  1970-03       Impact factor: 23.059

7.  Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease.

Authors:  C Fiocchi; K R Youngman; R G Farmer
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

8.  Enhanced local production of complement components in the small intestines of patients with Crohn's disease.

Authors:  O Ahrenstedt; L Knutson; B Nilsson; K Nilsson-Ekdahl; B Odlind; R Hällgren
Journal:  N Engl J Med       Date:  1990-05-10       Impact factor: 91.245

9.  Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe.

Authors:  R Tammi; J A Ripellino; R U Margolis; M Tammi
Journal:  J Invest Dermatol       Date:  1988-03       Impact factor: 8.551

10.  A new method for quantitation of ion fluxes across in vivo human gastric mucosa: effect of aspirin, acetaminophen, ethanol, and hyperosmolar solutions.

Authors:  A I Stern; D L Hogan; J I Isenberg
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.